EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Role of SLC39A8 .p.( Ala391Thr ) in Schizophrenia Symptom Severity and Cognitive Ability: Cross‐Sectional Studies of Schizophrenia and the General UK Population

Sophie E Smart iD, Sophie E Legge, Eilidh Fenner iD, Antonio F Pardiñas iD, Grace Woolway, Amy J Lynham iD, Valentina Escott-Price iD, Jeremy Hall, Lawrence Wilkinson, Peter Holmans, Michael C O'Donovan, Michael J Owen und 1 weitere

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · 2025

DOI: 10.1002/ajmg.b.33037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2025. Verfasst von Sophie E Smart und 12 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK. Hauptthemen laut MEDLINE: Schizophrenia, Cation Transport Proteins, Cognition. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust Integrative Neuroscience PhD Studentship, European Union's Horizon 2020, Academy of Medical Sciences Springboard.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The missense SNP NC_000004.12:g.102267552C>T (also known as SLC39A8.p.(Ala391Thr), rs13107325) in SLC39A8 encodes a zinc transporter. This SNP has been linked to schizophrenia and is the likely causal variant for one of the genome‐wide association loci associated with the disorder. Using regression analyses, we tested whether the schizophrenia‐risk allele at p.(Ala391Thr) was associated with schizophrenia‐related phenotypes, including positive, negative, and disorganized symptoms, cognitive ability, educational attainment, and age of psychosis onset, within three schizophrenia cohorts (combined N = 1232) and, with equivalent phenotypes, in a sample of population controls (UK Biobank, N = 355,069). We also used the population controls to test for associations with rare protein‐truncating and deleterious missense variants within SLC39A8 . Within the schizophrenia cohorts, after correction for multiple testing, p.(Ala391Thr) was not significantly associated with any schizophrenia‐related phenotypes. In the unaffected participants from the UK Biobank, the schizophrenia‐risk allele at p.(Ala391Thr) was associated with significantly poorer cognitive ability and fluid intelligence, a lower probability of obtaining GCSEs or a degree‐level qualification, and fewer years in education. There was no association between p.(Ala391Thr) and self‐reported psychotic experiences in this cohort. Rare variants in SLC39A8 were nominally associated with poorer cognitive ability, but these associations did not survive correction for multiple testing. The schizophrenia‐risk allele was associated with poorer cognitive ability, but not psychotic experiences, in a volunteer sample drawn from the general population. We found no evidence that p.(Ala391Thr) was associated with symptom severity in schizophrenia. To understand the impact of rare variants in SLC39A8 on cognitive impairment, larger independent samples are required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchizophreniaCation Transport ProteinsCognitionHumansMaleFemaleUnited KingdomCross-Sectional StudiesPolymorphism, Single NucleotideGenome-Wide Association StudyAdultMiddle AgedGenetic Predisposition to DiseaseAllelesPhenotypeMutation, MissenseZinc Transporter 8

Stichwörter der Autor:innen

ZIP8metal ion transporterspsychosisrs13107325whole‐exome sequencing

Substanzen

Cation Transport ProteinsSLC39A8 protein, humanZinc Transporter 8

Autor:innen und Institutionen

  • Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
  • Neuroscience and Mental Health Innovation Institute, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.

ORCID-Profile: Sophie E Smart, Eilidh Fenner, Antonio F Pardiñas, Amy J Lynham, Valentina Escott-Price, James T R Walters

Förderung

  • Wellcome Trust Integrative Neuroscience PhD Studentship
  • European Union's Horizon 2020
  • Academy of Medical Sciences Springboard
  • Medical Research Council Centre
  • Takeda Pharmaceuticals Ltd.
  • Wellcome Trust
  • NIMH NIH HHS
  • Medical Research Council

Zitieren

APA

Smart, S. E., Legge, S. E., Fenner, E., Pardiñas, A. F., Woolway, G., Lynham, A. J., Escott-Price, V., Hall, J., Wilkinson, L., Holmans, P., O'Donovan, M. C., Owen, M. J., & Walters, J. T. R. (2025). The Role of SLC39A8 .p.( Ala391Thr ) in Schizophrenia Symptom Severity and Cognitive Ability: Cross‐Sectional Studies of Schizophrenia and the General UK Population. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. https://doi.org/10.1002/ajmg.b.33037

Vancouver

Smart SE, Legge SE, Fenner E, Pardiñas AF, Woolway G, Lynham AJ, et al. The Role of SLC39A8 .p.( Ala391Thr ) in Schizophrenia Symptom Severity and Cognitive Ability: Cross‐Sectional Studies of Schizophrenia and the General UK Population. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2025. doi:10.1002/ajmg.b.33037

BibTeX
@article{Smart2025,
  author = {Smart, Sophie E and Legge, Sophie E and Fenner, Eilidh and Pardiñas, Antonio F and Woolway, Grace and Lynham, Amy J and Escott-Price, Valentina and Hall, Jeremy and Wilkinson, Lawrence and Holmans, Peter and O'Donovan, Michael C and Owen, Michael J and Walters, James T R},
  title = {The Role of SLC39A8 .p.( Ala391Thr ) in Schizophrenia Symptom Severity and Cognitive Ability: Cross‐Sectional Studies of Schizophrenia and the General UK Population},
  journal = {American Journal of Medical Genetics Part B: Neuropsychiatric Genetics},
  year = {2025},
  doi = {10.1002/ajmg.b.33037}
}
Kostenlos starten →